Cayman has opted to stay outside the framework of Solvency II equivalence—at least for now. Here, Cayman Captive explores the merits of the decision.
Significant health care reform is afoot in the US under the guise of the Patient Protection and Affordable Care Act. Developments are likely to have significant implications for Cayman and international captives.
Washington’s introduction of the Foreign Account Tax Compliance Act is creating additional concerns for offshore entities. Here, the implications of greater tax cooperation and transparency are explored.
With Solvency II imminent, US captives are watching Europe’s new regulatory regime with interest. Some believe its implications will be significant. Some are convinced otherwise. US Captive addresses both sides.
Pierre Sonigo outlines the progress of European regulatory developments and explains why expected changes are as easy to understand as counting from one to five.
Yvette Essen provides an overview of the captive market, and indicates that there is cause for both opportunity and caution, with regulatory developments likely to have a significant impact on the sector.
EMEA Captive examines perceptions of the Solvency II regime in its present form, and asks industry players whether the regime is appropriate to the captive sector.
With uncertainties continuing over offshore domiciles and the likely impact of Solvency II , Shaun Brook examines the potential of the Middle East as a growing and competitive captive hub.
With the BMA’s new code of conduct imminent, Paul O’Neill addresses its implicat ions for Bermuda’s captive sector.
Bermuda’s decision to opt for Solvency II equivalence will have an undoubted impact upon its captive sector. Bermuda Captive discusses the merits of the decision.